Nucore Health review

Nucore's useful idea is 'any dose': on its product pages glutathione is a flat $250/month, injectable NAD⁺ a flat $149/month and NAD⁺ nasal spray a flat $169/month, with no membership fee and no titration surcharge, which removes the single biggest source of surprise cost in this category. It describes itself as physician-owned, shows a LegitScript seal, covers all fifty states and runs care through OpenLoop Health. The catch is that the site's prices do not line up. The Energy & Anti-Aging page shows four cards labeled by goal rather than by drug, at 'as low as' $59 to $199 a month, while the named product pages carry the higher any-dose prices — and the sermorelin page says coming soon.

Nucore Health is the trading name of Nucore Technologies, LLC, a physician-owned telehealth platform serving all fifty states. Its site is organized as care routes: weight loss (including GLP-1 microdosing), men's and women's hair restoration, sexual health, growth hormone, longevity and energy, and a Fullscript supplement dispensary. The named longevity products are injectable NAD⁺ ($149/month any dose), NAD⁺ nasal spray ($169/month), glutathione ($250/month) and MIC B12 and MIC L-carnitine injections, with sermorelin listed but not yet orderable. Clinical care is provided in partnership with OpenLoop Health: you pick a treatment, complete a secure medical intake, and a licensed provider reviews eligibility and prescribes if appropriate.

Asynchronous and intake-led, with a no-frills commercial structure: no membership fee, no insurance required, FSA/HSA eligible, and no scheduled appointment. Orders typically ship in one to two business days once approved, and most products can be set to 30- or 90-day auto-renewal. A LegitScript seal is displayed with a link to LegitScript's checker, the company describes itself as physician-owned, and its FAQ states plainly that compounded medications are not FDA-approved and are prescribed off-label by licensed providers. Running care on OpenLoop is a real disclosure too: its About page says provider licensure details are available through OpenLoop on request. Two structural weaknesses. The legal documents are downloadable PDFs rather than web pages; that is where the Nucore Technologies, LLC name appears. And the catalog does not line up. The Energy & Anti-Aging page shows four cards — Cellular Energy (injection, nasal or oral) as low as $59/month, Metabolic Support (weekly injection) $79, Antioxidant Support (weekly injection) $99 and Sleep and Recovery (nightly injection) $199 — without naming the drug on any card, while the product pages for NAD⁺ and glutathione show $149 and $250, and the sermorelin product page shows a 'Coming Soon' panel. Confirm which product and which price you are being offered before you pay.

On the named product pages, glutathione is $250 per month, injectable NAD⁺ $149 and NAD⁺ nasal spray $169, each marked 'Any Dose', with no membership fee and FSA/HSA eligibility. The 'any dose' phrasing is the part that matters. In this category, a monthly figure is very often an entry tier that rises as a provider titrates you; a flat rate means the number you read is the number you keep paying. The Energy & Anti-Aging page tells a different story: goal-labeled cards 'as low as' $59, $79, $99 and $199 a month. The surrounding copy discusses NAD⁺, glutathione, sermorelin and MIC injections, so the cheaper cards may be lower prices for the same products, but no card names its drug, and 'as low as' is not the same promise as 'any dose'. Ask at intake which figure applies to you. Nucore's GLP-1 route lists compounded semaglutide from $179, oral semaglutide from $209 and compounded tirzepatide from $269 a month, while its individual semaglutide and tirzepatide product pages show $299 and $399 any dose; none of those is a peptide or NAD⁺ price. Sermorelin has no price because its product page reads coming soon.

Compounded; not FDA-approved. Prescription required only if a licensed provider finds it appropriate. Nucore states this itself — its FAQ describes compounded medications as not FDA-approved and prescribed off-label by licensed providers — which is a clear disclosure, though the compounding pharmacy is not named on the site, and compounded sterile preparations are not reviewed by the FDA for purity and potency the way approved drugs are. On the evidence, the live longevity products are weakly supported. Glutathione is the body's principal endogenous antioxidant, and the biology is real, but there is essentially no controlled human outcome trial data behind the detoxification, immune and skin claims made for injected glutathione — the human literature is small and largely cosmetic. NAD⁺ is the same story from a different direction: injected and intranasal NAD⁺ have no controlled human outcome trials, and the forms with human data are the oral precursors NR and NMN, which reliably raise blood NAD⁺ — a raised biomarker rather than a demonstrated clinical benefit. Sermorelin, when it is orderable, is a GHRH analog acting on a real pituitary axis with thin long-term outcome data. Individual results vary.